Feedback / Questions
AB001 - AKSO Biopharma
https://www.businesswire.com/news/home/20220727005360/en/AKSO-Announces-Publication-of-Preclinical-Data-Demonstrating-Engineered-Soluble-BCMA-Decoy-Receptor-AB001-Effectively-Inhibits-Multiple-Myeloma-and-Diffuse-Large-B-Cell-Lymphoma
Jul 27, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next